drugset / Trial / NCT04573036

A Trial of HRS4800 Tables in Healthy Male Subjects

NCT04573036 ↗

Phase 1 Completed 40 enrolled Atridia Pty Ltd.
RandomizedParallel-groupTriple-blindTreatment

Summary

This is a single-site study to evaluate the safety, tolerability and pharmacokinetics (PK) of single dose administration of HRS4800, and the effect of food on the PK of HRS4800 in healthy male subjects.

Timeline

Start
2020-11-12
Primary completion
2021-09-20
Completion
2021-09-20

Drugs

EvaluationDrugModalityDoseRoute
Subject HRS4800 Unknown — Oral

Indications

No indication recorded.